Scarica l'app Stockscreener
156.58
1.12%
-1.6624
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$158.24
Aprire:
$157.75
Volume 24 ore:
296.64K
Relative Volume:
0.14
Capitalizzazione di mercato:
$37.34B
Reddito:
$222.29B
Utile/perdita netta:
$1.56B
Rapporto P/E:
24.43
EPS:
6.41
Flusso di cassa netto:
$2.44B
1 W Prestazione:
-0.91%
1M Prestazione:
-5.13%
6M Prestazione:
+23.16%
1 anno Prestazione:
+57.22%
Intervallo 1D:
$153.81
$158.04
Intervallo di 1 settimana:
$152.59
$159.64
Portata 52W:
$96.05
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Confronta CAH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
156.46 | 37.86B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
704.26 | 88.80B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
281.13 | 56.91B | 310.23B | 1.69B | 3.58B | 8.62 |
|
HSIC
Henry Schein Inc
|
64.40 | 8.75B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.7701 | 681.98M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Indwelling Catheters Market Growth in Future Scope 2025-2032 | - openPR.com
Is Cardinal Health’s (CAH) Expanded Equity Rx Program and New Partnerships Shaping Its Investment Thesis? - simplywall.st
Is Cardinal Health Inc. a growth stock or a value stockAchieve rapid wealth accumulation through smart investing - Jammu Links News
What catalysts could drive Cardinal Health Inc. stock higher in 2025Get professional advice for portfolio optimization - Jammu Links News
What makes Cardinal Health Inc. stock price move sharplyCapitalize on momentum-driven stocks - jammulinksnews.com
Should I hold or sell Cardinal Health Inc. stock in 2025Achieve impressive returns with smart timing - Jammu Links News
What is Cardinal Health Inc. company’s growth strategyCapitalize on market trends with expert guidance - Jammu Links News
What are analysts’ price targets for Cardinal Health Inc. in the next 12 monthsFree AI-Backed Trading Signals - Jammu Links News
What are the technical indicators suggesting about Cardinal Health Inc.Consistently exceptional gains - Jammu Links News
When is Cardinal Health Inc. stock expected to show significant growthFree Consultation - Jammu Links News
What drives Cardinal Health Inc. stock priceInvest smarter with expert stock recommendations - Jammu Links News
How does Cardinal Health Inc. compare to its industry peersMaximize your portfolio’s growth potential - jammulinksnews.com
What are Cardinal Health Inc. company’s key revenue driversAchieve rapid portfolio growth with expert guidance - Jammu Links News
What analysts say about Cardinal Health Inc. stockUnlock daily market insights for better trades - Jammu Links News
Cardinal Health, Inc. (NYSE:CAH) Is a Favorite Amongst Institutional Investors Who Own 89% - 富途牛牛
Stock Analysis | Cardinal Health OutlookNavigating Mixed Signals in a Weak Technical Environment - AInvest
Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution - Yahoo.co
How does Cardinal Health Inc. generate profit in a changing economyAdvanced Screener Report With High Returns - Jammu Links News
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health Foundation aims to improve prescription recycling, medication availability - AOL.com
Cardinal Health Foundation expands Equity Rx to increase access to prescription medications, bringing total investment to $5M - Yahoo Finance
Why Cardinal Health Inc. stock attracts strong analyst attentionDaily Momentum Screener With Alerts Launched - beatles.ru
Cardinal Health Inc. Recovery Likely Here’s What Data ShowsStep-by-Step Stock Investment Guide Gains Popularity - metal.it
Published on: 2025-07-29 13:14:51 - metal.it
AI Tools Suggest Cardinal Health Inc. May Outperform This WeekOptimized Watchlist With Daily Adjustments Launched - metal.it
Is it the right time to buy Cardinal Health Inc. stockGet timely alerts on market opportunities - jammulinksnews.com
Is Cardinal Health Inc. stock overvalued or undervaluedBuild wealth with long-term growth strategies - jammulinksnews.com
Skin Biopsy Market Set to Witness Significant Growth by 2033 | - openPR.com
What are the latest earnings results for Cardinal Health Inc.Turn volatility into profit opportunities - jammulinksnews.com
Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel - Yahoo Finance
Here's Why We Think Cardinal Health (NYSE:CAH) Might Deserve Your Attention Today - simplywall.st
What institutional investors are buying Cardinal Health Inc. stockStay ahead with advanced stock screening tools - jammulinksnews.com
How volatile is Cardinal Health Inc. stock compared to the marketBeginner Investor Review Backed By Experts - jammulinksnews.com
Cardinal Health Earnings Preview: What to Expect - MSN
How many analysts rate Cardinal Health Inc. as a “Buy”Achieve explosive financial results today - jammulinksnews.com
Cardinal Health (CAH) Beat the Market in 2025 with Solid Healthcare Momentum - MSN
Is Cardinal Health Inc. a good long term investmentExponential wealth increase - PrintWeekIndia
Universal Health to Report Q2 Earnings: What Do the Key Estimates Say? - TradingView
Investors Will Want Cardinal Health's (NYSE:CAH) Growth In ROCE To Persist - Yahoo Finance
Are Medical Stocks Lagging Cardinal Health (CAH) This Year? - Yahoo Finance
Cardinal Health Set to Announce Q4 Earnings with Promising Growth ProspectsNews and Statistics - IndexBox
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.89%
3.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):